Tisento’s MELAS treatment receives fast track status from FDA
Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.
Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.
What's Your Reaction?
